BR100 Increased By (0.37%)
BR30 Increased By (0.26%)
KSE100 Increased By (0.14%)
KSE30 Increased By (0.03%)
BECO 5.93 Decreased By ▼ -0.10 (-1.66%)
BML 57.50 Increased By ▲ 4.75 (9%)
BOP 34.20 Decreased By ▼ -0.05 (-0.15%)
CNERGY 8.21 Increased By ▲ 0.05 (0.61%)
DCL 12.15 Decreased By ▼ -0.19 (-1.54%)
FCCL 53.90 Increased By ▲ 0.01 (0.02%)
FCSC 5.27 Increased By ▲ 0.05 (0.96%)
FFL 18.00 Decreased By ▼ -0.03 (-0.17%)
FNEL 1.32 Increased By ▲ 0.02 (1.54%)
HUMNL 11.22 Increased By ▲ 0.22 (2%)
KEL 8.12 Increased By ▲ 0.01 (0.12%)
KOSM 5.45 Increased By ▲ 0.07 (1.3%)
MLCF 88.60 Increased By ▲ 0.55 (0.62%)
NBP 186.06 Decreased By ▼ -0.42 (-0.23%)
PACE 10.95 Increased By ▲ 0.23 (2.15%)
PAEL 40.45 Increased By ▲ 0.51 (1.28%)
PIAHCLA 26.30 Increased By ▲ 0.13 (0.5%)
PIBTL 17.32 No Change ▼ 0.00 (0%)
PPL 232.92 Increased By ▲ 0.14 (0.06%)
PRL 34.90 Decreased By ▼ -0.05 (-0.14%)
PTC 66.75 Decreased By ▼ -0.81 (-1.2%)
SEARL 91.50 Increased By ▲ 0.57 (0.63%)
SSGC 27.16 Decreased By ▼ -0.01 (-0.04%)
TELE 8.66 Increased By ▲ 0.09 (1.05%)
THCCL 64.77 Increased By ▲ 4.64 (7.72%)
TPLP 9.16 Increased By ▲ 0.40 (4.57%)
TREET 24.68 Increased By ▲ 0.14 (0.57%)
TRG 72.55 Increased By ▲ 0.80 (1.11%)
WAVES 10.60 Increased By ▲ 0.62 (6.21%)
WTL 1.28 Increased By ▲ 0.02 (1.59%)
Markets

China stocks gain as country approves first CAR-T cell therapy

  • The yuan was quoted at 6.4807 per US dollar, 0% firmer than the previous close of 6.481.
Published June 23, 2021 Updated June 23, 2021 11:40am
By

SHANGHAI: China shares rose on Wednesday, with healthcare stocks leading the gains after the country approved its first CAR-T cell therapy, while investors cheered the Federal Reserve's assurance that the US central bank will not hasten to hike rates.

** At the midday break, the Shanghai Composite index was up 0.46% at 3,573.61 points, rising for the third consecutive day. China's blue-chip CSI300 index was up 0.77%.

** The financial sector sub-index climbed 0.13%, the consumer staples sector was down 1.24%, while the real estate index added 0.13%.

** Chinese H-shares listed in Hong Kong rose 1.43% to 10,619.02, while the Hang Seng Index was up 1.46% at 28,721.85.

** The smaller Shenzhen index was up 0.81%, the start-up board ChiNext Composite index advanced 1.63%, and Shanghai's tech-focused STAR50 index climbed 1.53%?.

** The largest percentage gainers in the main Shanghai Composite index were Liaoning SG Automotive Group Co Ltd, up 10.1%, followed by Anhui Jianghuai Automobile Group Corp Ltd , gaining 10.05%.

** Shanghai-listed shares of Shanghai Fosun Pharmaceutical Group Co Ltd rose as much as 3.4% after China approved the first CAR-T cell therapy in the country as a joint venture of Fosun Pharmaceutical had obtained the rights to sell the therapy in China.

** Leading the gains, the healthcare sub-index rose 1.11%.

** Lifting investors' risk appetite was Fed chief Jerome Powell's reassurance of the goal of a broad labour market recovery while he also said fear of inflation alone would not be enough to prompt rate rises.

** China's state planner said on Wednesday that it and the market regulator have recently sent teams to various areas to look into commodities prices and supplies and would learn about mid- and downstream companies' situations.

** Around the region, MSCI's Asia ex-Japan stock index was firmer by 0.74% while Japan's Nikkei index was up 0.02%.

** The yuan was quoted at 6.4807 per US dollar, 0% firmer than the previous close of 6.481.

Comments

Comments are closed for this article.